Betahistine
Back to searchMolecule Structure
Scientific Name
Betahistine
Description of the Drug
Betahistine is an antivertigo agent used for the reduction of episodes of vertigo association with Ménière’s disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06698
http://www.drugbank.ca/drugs/DB06698
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H3 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL264 |
| Histamine H1 receptor | SINGLE PROTEIN | AGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL125582 | |
| PharmGKB | PA165958372 | |
| Human Metabolome Database | HMDB0015644 | |
| DrugBank | DB06698 | |
| PubChem: Thomson Pharma | 15119994 | |
| PubChem | 2366 | |
| Mcule | MCULE-3539516594 | |
| LINCS | LSM-4044 | |
| Nikkaji | J8.042J | |
| BindingDB | 96589 | |
| EPA CompTox Dashboard | DTXSID3022665 | |
| DrugCentral | 346 | |
| ChemicalBook | CB4489793 | |
| rxnorm | BETAHISTINE | BETAHISTINE HYDROCHLORIDE |
| ChEBI | 35677 | |
| ZINC | ZINC000001675415 |
